Clinical Trial Update: Molecular Imaging of Plaque Vulnerability [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on molecular imaging of plaque vulnerability in atherosclerotic plaque.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Plaque, Atherosclerotic | Phase 3 | Status: UNKNOWN